CCCC Market Cap History



Below is a table of the CCCC market cap history going back to 10/2/2020:

Date CCCC Market Cap
10/2/20201.04B
11/10/20201.11B
3/1/20211.83B
5/3/20211.45B
8/2/20212.17B
11/1/20212.24B
2/15/20221.16B
4/25/2022456.25M
7/27/2022522.89M
10/26/2022446.49M
2/15/2023283.02M
4/25/2023149.64M
7/31/2023191.35M
10/25/202368.01M
2/14/2024501.47M

Also see: CCCC Shares Outstanding History
and CCCC YTD Return
CCCC Historical Market Cap:
-19.45% CAGR
CCCC Historical Market Cap: +-19.45% CAGR

Mouse over chart for data details
10/2/2020 ...2/14/2024
C4 Therapeutics is a clinical-stage biopharmaceutical company focused on advancing targeted protein degradation science to develop a new generation of small-molecule medicines to transform how disease is treated. Co.'s primary advanced product candidate, CFT7455, is an orally bioavailable MonoDAC degrader of protein targets called IKZF1 and IKZF3 in clinical development for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. Co. is also developing CFT8634, an orally bioavailable Bifunctional Degradation Activating Compounds degrader of a protein target called BRD9, for synovial sarcoma and SMARCB1-deleted solid tumors. We show 15 historical shares outstanding datapoints in our CCCC shares outstanding history coverage, used to compute CCCC market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CCCC market cap history over the course of time is important for investors interested in comparing CCCC's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CCCC versus a peer is one thing; comparing CCCC market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CCCC can fluctuate over the course of history. With this page we aim to empower investors researching CCCC by allowing them to research the CCCC market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree CCCC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
C4 Therapeutics (CCCC) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CCEL Market Cap History
CCRN Market Cap History
CCXI Market Cap History
CDAK Market Cap History
CDMO Market Cap History
CDNA Market Cap History
CDRE Market Cap History
CDTX Market Cap History
CDXC Market Cap History
CELC Market Cap History
More Healthcare companies »

 

CCCC Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.